Aflac Inc AFL
We take great care to ensure that the data presented and summarized in this overview for AFLAC INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding AFL
View all-
Japan Post Holdings Co., Ltd.52.3MShares$4.62 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA51.7MShares$4.57 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY41.1MShares$3.63 Billion0.08% of portfolio
-
State Street Corp Boston, MA25.8MShares$2.28 Billion0.1% of portfolio
-
Wells Fargo & Company San Francisco, CA16.3MShares$1.44 Billion0.34% of portfolio
-
Geode Capital Management, LLC Boston, MA12.4MShares$1.09 Billion0.1% of portfolio
-
Morgan Stanley New York, NY8.79MShares$777 Million0.06% of portfolio
-
Northern Trust Corp Chicago, IL6.56MShares$580 Million0.1% of portfolio
-
Legal & General Group PLC London, X05.47MShares$484 Million0.11% of portfolio
-
First Trust Advisors LP Wheaton, IL5.38MShares$475 Million0.48% of portfolio
Latest Institutional Activity in AFL
Top Purchases
Top Sells
About AFL
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is based in Columbus, Georgia.
Insider Transactions at AFL
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 08
2024
|
Joseph L Moskowitz Director |
SELL
Open market or private sale
|
Direct |
600
-2.13%
|
$50,400
$84.84 P/Share
|
|
May 07
2024
|
Katherine Rohrer Director |
SELL
Bona fide gift
|
Direct |
900
-4.21%
|
-
|
|
May 06
2024
|
Miwako Hosoda Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,125
+27.31%
|
-
|
|
May 06
2024
|
Katherine Rohrer Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,125
+9.04%
|
-
|
|
May 06
2024
|
Joseph L Moskowitz Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,125
+7.02%
|
-
|
|
May 06
2024
|
William P Bowers Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,781
+6.68%
|
-
|
|
May 06
2024
|
Arthur Reginald Collins Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,125
+21.56%
|
-
|
|
May 06
2024
|
Georgette D. Kiser Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,125
+10.82%
|
-
|
|
May 06
2024
|
Thomas J Kenny Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,125
+9.58%
|
-
|
|
May 06
2024
|
Karole Lloyd Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,125
+4.32%
|
-
|
|
May 06
2024
|
Nobuchika Mori Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,125
+14.5%
|
-
|
|
May 01
2024
|
Nobuchika Mori Director |
SELL
Payment of exercise price or tax liability
|
Direct |
721
-6.48%
|
$60,564
$84.57 P/Share
|
|
May 01
2024
|
Miwako Hosoda Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,514
-30.01%
|
$127,176
$84.57 P/Share
|
|
Apr 29
2024
|
Max Broden EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,894
-8.24%
|
$747,096
$84.54 P/Share
|
|
Mar 25
2024
|
Bradley Eugene Dyslin Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
5,368
-32.08%
|
$450,912
$84.81 P/Share
|
|
Mar 20
2024
|
Thomas J Kenny Director |
SELL
Open market or private sale
|
Direct |
5,000
-21.82%
|
$420,000
$84.62 P/Share
|
|
Mar 14
2024
|
Albert Riggieri SVP, Global CRO |
SELL
Open market or private sale
|
Direct |
8,000
-19.6%
|
$664,000
$83.34 P/Share
|
|
Feb 22
2024
|
Arthur Reginald Collins Director |
SELL
Open market or private sale
|
Direct |
3,000
-34.92%
|
$237,000
$79.73 P/Share
|
|
Feb 21
2024
|
Daniel P Amos Chairman of the Board, CEO |
SELL
Bona fide gift
|
Direct |
112,800
-12.38%
|
-
|
|
Feb 16
2024
|
Charles D Lake Ii Chairman & Rep. Director, ALIJ |
SELL
Open market or private sale
|
Direct |
32,259
-34.4%
|
$2,548,461
$79.91 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 738K shares |
|---|---|
| Exercise of conversion of derivative security | 106K shares |
| Open market or private purchase | 2.5K shares |
| Bona fide gift | 1.52K shares |
| Discretionary transaction | 371 shares |
| Open market or private sale | 341K shares |
|---|---|
| Payment of exercise price or tax liability | 276K shares |
| Bona fide gift | 240K shares |